Understand the source comparison
Comparison Table: KPV vs Five Commonly Studied Research Peptides
The following table compares KPV peptide to five of the most frequently studied research peptides based on primary mechanism, receptor targets, studied applications, typical research dosage ranges, and key differentiators. KPV NF-κB inhibition via α-MSH pathwa
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The following table compares KPV peptide to five of the most frequently studied research peptides based on primary mechanism, receptor targets, studied applications, typical research dosage ranges, and key differentiators.
- KPV
- NF-κB inhibition via α-MSH pathway
- MC1R, MC3R melanocortin receptors
- Inflammatory bowel disease models, chronic dermatitis, antimicrobial studies
- 10–100 μM
- Only peptide in this group that works through melanocortin signaling; dual anti-inflammatory and antimicrobial action
- BPC-157
- VEGF upregulation and angiogenesis promotion
- No specific receptor identified (likely integrin-mediated)
- Tendon/ligament repair, gastric ulcer models, vascular injury
- 1–10 μg/mL
- Primarily studied for structural tissue repair; works downstream of inflammation rather than at transcriptional level
- TB-500 (Thymosin β4)
- Actin sequestration and cell migration facilitation
- G-actin binding (non-receptor mechanism)
- Wound healing models, cardiac injury, corneal repair
- 100–500 ng/mL
- Regulates cytoskeletal dynamics; promotes cell migration without directly affecting inflammatory cytokine transcription
- GHK-Cu (Copper Peptide)
- Collagen synthesis and matrix metalloproteinase modulation
- Integrin receptors, copper transport proteins
- Skin aging models, wound healing, anti-fibrotic studies
- 1–10 μM
- Requires copper ion for activity; primarily works through extracellular matrix remodeling rather than immune modulation
- LL-37 (Cathelicidin)
- Membrane disruption and LPS neutralization
- Direct membrane interaction (non-receptor)
- Antimicrobial studies, sepsis models, immune defense
- 5–50 μg/mL
- Constitutive immune defense peptide; antimicrobial action is primary, anti-inflammatory is secondary (opposite of KPV)
- Epithalon (Epitalon)
- Telomerase activation and pineal gland regulation
- Putative telomerase enzyme interaction
- Aging research, circadian rhythm studies, longevity models
- 0.1–1 μM
- Works through gene-level regulation of aging pathways; completely unrelated mechanism to inflammatory or structural peptides